198 related articles for article (PubMed ID: 786397)
1. Genetic resistance to marrow transplantation as a leukemia defense mechanism.
Gallagher MT; Lotzová E; Trentin JJ
Biomedicine; 1976 Feb; 25(1):1-3. PubMed ID: 786397
[TBL] [Abstract][Full Text] [Related]
2. Genetic resistance to bone marrow transplantation as a leukemia-lymphoma defense mechanism: correlation of "in vivo" lymphoma resistance and "in vitro" NK activity.
Gallagher MT; Datta SK; Trentin JJ
Biomedicine; 1980 May; 33(3):73-5. PubMed ID: 7004513
[TBL] [Abstract][Full Text] [Related]
3. Specific inhibition of hybrid resistance in F1 hybrid mice pretreated with parent-strain spleen cells. II. Evidence for an Hh-1 antigen-specific tolerization.
Kosmatopoulos K; Scott-Algara D; Halle-Pannenko O
J Immunol; 1988 Nov; 141(10):3285-92. PubMed ID: 2460528
[TBL] [Abstract][Full Text] [Related]
4. Genetic resistance to lymphoma-leukemia: role of natural killer cells in the rejection of lymphoma grafts.
Datta SK; Trentin JJ
Biomed Pharmacother; 1993; 47(10):451-6. PubMed ID: 8061245
[TBL] [Abstract][Full Text] [Related]
5. "Xenogeneic resistance" to rat bone marrow transplantation. III. Maturation age, and abrogation with cyclophosphamide, Corynebacterium parvum and fractionated irradiation.
Rauchwerger JM; Gallagher MT; Monié HJ; Trentin JJ
Biomedicine; 1976 Jan; 24(1):20-5. PubMed ID: 773442
[TBL] [Abstract][Full Text] [Related]
6. Specific inhibition of hybrid resistance in F1 hybrid mice pretreated with parent strain spleen cells. I. Induction of a nylon-adherent, Thy-1+Lyt-1+2- suppressor cell.
Kosmatopoulos K; Orbach-Arbouys S
J Immunol; 1987 Feb; 138(3):704-12. PubMed ID: 2879865
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of hybrid resistance by 5-fluorouracil. Destruction of a Thy-1+ Lyt-1+2- spleen cell implicated in the expression of hybrid resistance.
Kosmatopoulos K; Bravo-Cuellar A; Wachowiak J; Orbach-Arbouys S
Transplantation; 1987 Aug; 44(2):202-8. PubMed ID: 2888223
[TBL] [Abstract][Full Text] [Related]
8. Hemopoietic reconstitution obtained in F1 hybrids by grafting of parental marrow cells.
von Boehmer H; Sprent J; Nabholz M
Transplant Proc; 1976 Sep; 8(3):355-8. PubMed ID: 136073
[TBL] [Abstract][Full Text] [Related]
9. Modulation of F1 cytotoxic potentials by GvHR: role and mode of action of non-MHC genes that determine the hybrid resistance to GvHR-associated suppression of F1 cytotoxic potential.
Ishikawa H; Kubota E; Saito K
J Immunol; 1984 May; 132(5):2218-25. PubMed ID: 6232314
[TBL] [Abstract][Full Text] [Related]
10. Expression of antigens coded in murine leukemia viruses on thymocytes of allogeneic donor origin in AKR mice following syngeneic or allogeneic bone marrow transplantation.
Wustrow TP; Good RA
Cancer Res; 1985 Dec; 45(12 Pt 1):6428-35. PubMed ID: 2998600
[TBL] [Abstract][Full Text] [Related]
11. An investigation into the influence of a graft-versus-host reaction, induced by parent line cells, on the growth of lymphoma transplants in F1 hybrid mice.
Palmer AM; Symes MO
Folia Biol (Praha); 1974; 20(1):26-35. PubMed ID: 4154872
[No Abstract] [Full Text] [Related]
12. T killer cells play a role in allogeneic bone marrow graft rejection but not in hybrid resistance.
Dennert G; Anderson CG; Warner J
J Immunol; 1985 Dec; 135(6):3729-34. PubMed ID: 3905963
[TBL] [Abstract][Full Text] [Related]
13. [Graft versus host reaction and hybrid resistance in experimental models and clinical practice].
Clerici M; Villa ML; Clerici E
Boll Ist Sieroter Milan; 1988; 67(3):177-96. PubMed ID: 3072013
[TBL] [Abstract][Full Text] [Related]
14. [Influence of the maternal effect on allogenic inhibition of hematopoietic stem cells].
Golovistikov IN; Gambarov SS
Genetika; 1976; 12(6):70-4. PubMed ID: 11151
[TBL] [Abstract][Full Text] [Related]
15. Genetically determined resistance to foreign bone marrow transplantation in mice: characterization of the effector cells.
Miller SC
J Immunol; 1983 Jul; 131(1):92-7. PubMed ID: 6345669
[TBL] [Abstract][Full Text] [Related]
16. Modulation of F1 cytotoxic potentials by graft-vs-host reaction. Cooperative non-H-2- and H-2D region-gene control of F1 natural resistance to graft-vs-host reaction-associated immunosuppression.
Ishikawa H; Saito K; Kubota E
J Immunol; 1989 Mar; 142(5):1495-9. PubMed ID: 2918225
[TBL] [Abstract][Full Text] [Related]
17. Murine cytomegalovirus infection can enhance hybrid resistance through modulation of host natural killer activity.
Muluk SC; Hakim FT; Shearer GM
J Immunol; 1990 Aug; 145(4):1113-9. PubMed ID: 2166108
[TBL] [Abstract][Full Text] [Related]
18. Development of donor-derived thymic lymphomas after allogeneic bone marrow transplantation in AKR/J mice.
Yasumizu R; Hiai H; Sugiura K; Oyaizu N; Fan HX; Ohnishi Y; Iwai H; Inaba M; Kakinuma M; Onoe K
J Immunol; 1988 Sep; 141(6):2181-6. PubMed ID: 3049801
[TBL] [Abstract][Full Text] [Related]
19. The effects of polyinosinic:polycytidylic acid (pI:C) on the graft-vs-host (GVH) reaction. II. Increased NK-mediated rejection on C57BL/6 lymphocytes by (C57BL/6 X A)F1 mice.
Peres A; Nestel FP; Seemayer TA; Lapp WS
J Immunol; 1986 Dec; 137(11):3420-7. PubMed ID: 3537120
[TBL] [Abstract][Full Text] [Related]
20. F1 resistance to AKR lymphoma cells in vivo and in vitro.
Schmitt-Verhulst A-M ; Zatz MM
J Immunol; 1977 Jan; 118(1):330-3. PubMed ID: 830755
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
